www.黄在线看_国产成人午夜精品影院游乐网_国产成人久久av免费高清蜜臀_久久久999久久久_午夜 国产_一区二区三区四区国产

加入收藏 | 設為首頁 | 聯系我們

產品搜索

聯系我們

聯系人:蔣經理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區緯地路9號
Email: zhangxiangwen@cobioer.com

產品展示 / PRODUCTS
藥靶細胞株 > kinase激酶細胞株 > CBP73001BCR-ABL1/BaF3激酶細胞

BCR-ABL1/BaF3激酶細胞
名稱 BCR-ABL1/BaF3激酶細胞
型號 CBP73001
報價
特點 BCR-ABL1/BaF3激酶細胞,母細胞:BaF3,凍存條件:90% FBS+10% DMSO;
  • 詳細內容

CBP73001

I. Introduction

Cell Line Name:

BCR-ABL1/BaF3

Host Cell:

Ba/F3

Stability:16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)

Application:

Anti-proliferation assay and PD assay

Freeze Medium:

90% FBS+10% DMSO

Complete Culture Medium:

RPMI-1640+10%FBS

Mycoplasma Status:

Negative

II.Background

Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes.

ABL1 is a tyrosine kinase, and, in normal cells, it plays a role in cellular differentiation and regulation of the cell cycle. The BCR-ABL1 fusion gene creates a constitutively active tyrosine kinase, which leads to uncontrolled proliferation.

Imatinib is the first-generation ABL tyrosine kinase inhibitor, and it was approved by the FDA in 2001; label indications for CML include use in newly diagnosed adult and pediatric patients and in patients after failure of interferon-alpha therapy. While treatment responses to imatinib are often dramatic and lasting, 30–40% of patients will eventually need further treatment (Santos et al. 2011). In many but not all cases, this is due to the acquisition of point mutations in the tyrosine kinase domain of the BCR-ABL1 fusion gene, which renders the protein insensitive to the inhibitory effect of imatinib. This type of disease progression led to the development of second-line TKIs: dasatinib, nilotinib, and bosutinib. Dasatinib and bosutinib have the additional advantage of being inhibitors of SRC.

The second-generation TKIs, dasatinib, nilotinib, and bosutinib, are more potent than imatinib, and they were developed to treat cases of CML resistant to imatinib. Dasatinib and nilotinib are approved for use in CML in newly diagnosed adults, while dasatinib, nilotinib, and bosutinib are approved for use in adults with resistance or intolerance to prior therapy that included imatinib (FDA 2012). Soverini et al. (2011) made mutation-specific treatment decision recommendations that were adopted by NCCN (2012). Recommendations based on preclinical data are as follows: for T315I, HSCT or clinical trial; for V299L, T315A, and F317L/V/I/C, consider nilotinib rather than dasatinib; for Y253H, E255K/V, and F359V/C/I, consider dasatinib rather than nilotinib; and for all other mutations, consider high-dose imatinib, dasatinib, or nilotinib.

Ponatinib is a third-line TKI, developed specifically to address imatinib resistance due to the BCR-ABL1 T315I resistance mutation. Ponatinib is currently being investigated in phase III clinical trials.


III. Representative Data

1. WB of  BCR-ABL1/BaF3 expression



2. Sanger of BCR-ABL1/BaF3

Figure 2. BCR-ABL1/BaF3 Fusion

3. Anti-proliferation assay

Figure 3. CTG Proliferation Assay of BaF3 BCR-ABL1 WT Cells (C3).



如果你對CBP73001BCR-ABL1/BaF3激酶細胞感興趣,想了解更詳細的產品信息,填寫下表直接與廠家聯系:


留言框

  • 產品:

  • 您的單位:

  • 您的姓名:

  • 聯系電話:

  • 常用郵箱:

  • 省份:

  • 詳細地址:

  • 補充說明:

  • 驗證碼:

    請輸入計算結果(填寫阿拉伯數字),如:三加四=7

化工儀器網

推薦收藏該企業網站
主站蜘蛛池模板: 性生大片 | 亚洲av永久无码嘿嘿嘿 | 激情毛片视频在线播放 | 毛片黄色视频 | 日本亚州在线播放精品 | 日韩免费高清视频网站 | 美女脱了内裤张开腿让男人添 | 天天天天色 | 一区二区三区免费视频播放器 | 一级片特级片 | 国产成人精品一区二三区 | 日本一区二区免费电影 | 精品女同一区二区三区免费播放 | 大乳妇女bd视频在线观看 | 大学生寝室白袜自慰gay网站 | 日本高清一级做a爱过程免费视频 | 免费a级毛片在线播放不收费 | 国产精品久久毛片av大全日韩 | 久久久久无码精品国产app | 爱爱客影院在线影院gf发现 | 天天射天天干天天色 | 夜色毛片永久免费 | 亚洲v欧美v国产v在线观看 | 91精品久久久久久久99蜜桃 | 日本中文字幕一区二区 | 国精产品一区一区三区有限在线 | 在线观看国产精品av | 在线播放a 1 | 免费a级毛片无码a∨男男 | 午夜福利电影 | 中文字幕在线免费 | 今野由爱毛片在线播放 | 天天成人综合网 | 国产亚洲精品精品精品 | 国产成人综合91香蕉 | 蜜臀av999无码精品国产专区 | 青草草视频在线观看 | 夜爽8888视频在线观看 | www日本免费视频 | 亚洲日韩一区二区一无码 | 亚洲国产精品久久久天堂 |